Patent Assignment
Reel/Frame 064576/0500
Corrective Assignment to Correct the Assignment Document Previously Recorded at Reel: 057326 Frame: 0322. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2023-08-14
Pages: 8
Assignor
HUANG, CAI GU
Executed: 2021-08-20
Assignee
ANOVENT PHARMACEUTICAL (U.S.), LLC
ONE GATEWAY CENTER, SUITE 2600, NEWARK, NEW JERSEY, 07102
Covered Properties
(25)
Inhalation Atomizer Comprising a Blocking Function and a Counter
Inhalation Device for Administering Powdered Pharmaceutical Composition
Application:
16/837,499 →
Publication:
US 2020/0324064
Inhalable Formulation of a Solution Containing Vilanterol Trifenatate and Umeclidinium Bromide
Inhalable Formulation of a Solution Containing Indacaterol Maleate and Glycopyrronium Bromide
Application:
16/890,528 →
Publication:
US 2020/0375945
Inhalable Formulation of a Solution Containing Formoterol Fumarate and Aclidinium Bromide
Application:
16/910,860 →
Publication:
US 2020/0405700
Cartridge with Single-Layer Container and Its Nozzle-Shaped Cap for Nebulization Inhalation
Application:
16/941,974 →
Publication:
US 2021/0030978
Formulation of Antibody Based Drugs for Treating Lung Cancer by Inhalation
Application:
16/942,339 →
Publication:
US 2021/0030868
Liposome Formulation of Fluticasone Furoate and Method of Preparation
Propellant-Free Formulation for Inhalation
Application:
17/137,559 →
Publication:
US 2021/0205223
Liposome Formulation of Vilanterol Trifenatate
Inhalable Formulation of a Solution Containing Glycopyrrolate and Olodaterol Hydrochloride
Application:
17/152,049 →
Publication:
US 2021/0220367
Pharmaceutical Formulation Containing Remdesivir
Application:
17/168,262 →
Publication:
US 2021/0252027
Inhalable Formulation of a Solution Containing Levalbuterol Tartrate
Application:
17/205,660 →
Publication:
US 2021/0290568
Inhalable Formulation of a Solution Containing Olodaterol
Application:
17/231,727 →
Publication:
US 2021/0322309
Inhalable Formulation of a Solution Containing Tiotropium Bromide and Olodaterol
Application:
17/231,821 →
Publication:
US 2021/0322311
Pharmaceutical Formulation Containing Active Metabolites of Remdesivir for Inhalation
Application:
17/316,933 →
Publication:
US 2021/0346288
Pharmaceutical Formulation Containing Remdesivir and Its Active Metabolites for Dry Powder Inhalation
Application:
17/323,109 →
Publication:
US 2021/0353650
Pharmaceutical Formulation Containing Umeclidinium Bromide and Vilanterol Trifenatate
Pharmaceutical Formulation Containing Glycopyrrolate and Indacaterol Maleate
Application:
17/342,859 →
Publication:
US 2021/0386730
Preparation of a Pharmaceutical Composition of Olodaterol and Budesonide
Application:
17/354,140 →
Publication:
US 2022/0031712
Preparation of a Pharmaceutical Composition of Olodaterol, Tiotropium Bromide and Budesonide
Application:
17/354,345 →
Publication:
US 2021/0393521
Pharmaceutical Formulation Containing Active Metabolites of Remdesivir or Its Analog for Inhalation
Application:
17/354,702 →
Publication:
US 2021/0393663
Pharmaceutical Formulation Containing Combination of M3 Antagonist-Beta-2 Agonist and Inhaled Corticosteroids
Application:
17/361,471 →
Publication:
US 2021/0401855
Formulation of Tocilizumab and Method for Treating Covid-19 by Inhalation
Biopharmaceutical Formulation of Anti-Pd-1, Anti-Pd-L1, and Anti-Vegfr Therapeutic Monoclonal Antibodies and Method for Treating Nsclc by Inhalation
Application:
17/362,218 →
Publication:
US 2021/0403568
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 30, 2021
From: ZHAO, YUE
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057327/0414 →
Assignment of Assignor's Interest
Aug 30, 2021
From: YUAN, HUI
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0522 →
Assignment of Assignor's Interest
Aug 30, 2021
From: CAI, JIAN
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0610 →
Assignment of Assignor's Interest
Aug 30, 2021
From: WU, JIAN JIANG
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0685 →
Assignment of Assignor's Interest
Aug 30, 2021
From: LI, LIANG
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0734 →
Assignment of Assignor's Interest
Aug 30, 2021
From: ZHANG, LU LU
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0823 →
Assignment of Assignor's Interest
Aug 30, 2021
From: HE, NING
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0935 →
Assignment of Assignor's Interest
Aug 30, 2021
From: GU, PENG PENG
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057327/0079 →
Assignment of Assignor's Interest
Aug 30, 2021
From: WANG, XIAO QIAN
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057327/0180 →
Assignment of Assignor's Interest
Aug 30, 2021
From: XU, YING AI
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057327/0329 →
Assignment of Assignor's Interest
Aug 30, 2021
From: HUSSAIN, ABID
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057325/0672 →
Assignment of Assignor's Interest
Aug 30, 2021
From: ZHANG, HAI LONG
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057325/0917 →
Assignment of Assignor's Interest
Aug 30, 2021
From: HUANG, HUA
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0122 →
Assignment of Assignor's Interest
Aug 30, 2021
From: HUANG, CAI GU
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0322 →
Assignment of Assignor's Interest
Aug 30, 2021
From: HUANG, XIAO TING
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0414 →
Change of Name
Jun 13, 2023
From: ANOVENT PHARMACEUTICAL (U.S.), LLC
To: ANOBRI PHARMACEUTICALS US, LLC
Reel/Frame 063983/0307 →
Corrective Assignment to Correct the the Assignment Document Previously Recorded at Reel: 057325 Frame: 0672. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: HUSSAIN, ABID
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064576/0383 →
Corrective Assignment to Correct the the Assignment Document Previously Recorded at Reel: 057326 Frame: 0522. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: YUAN, HUI
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064576/0415 →
Corrective Assignment to Correct the Assignment Document Previously Recorded on Reel 057326 Frame 0734. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: LI, LIANG
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064576/0427 →
Corrective Assignment to Correct the Assignment Document Previously Recorded at Reel: 057325 Frame: 0917. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: ZHANG, HAI LONG
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064576/0257 →
Corrective Assignment to Correct the Assignment Document Previously Recorded on Reel 057327 Frame 0414. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: ZHAO, YUE
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064576/0781 →
Corrective Assignment to Correct the Assignment Document Previously Recorded on Reel 057327 Frame 0329. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: XU, YING AI
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064576/0791 →
Corrective Assignment to Correct the Assignment Document Previously Recorded at Reel: 057326 Frame: 0414. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: HUANG, XIAO TING
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064673/0474 →
Corrective Assignment to Correct the Assignment Document Previously Recorded on Reel 057326 Frame 0935. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: HE, NING
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064576/0477 →